The SMA Clinical Trial Readiness Program: creation and evaluation of a program to enhance SMA trial readiness in the United States

por Peterson, Ilse, Cruz, Rosángel, Sarr, Fatou, Stanley, Ann Marie, Jarecki, Jill
Publicado 2020

683. Understanding Clostridioides difficile toxinB gene conservation through surveillance of public data

por Mulholland, Kelly, Godfrey, Victoria, Stanley, Ann Marie, Brady, Tyler, Sellman, Bret R, Tkaczyk, Christine, Gopalakrishnan, Vancheswaran
Publicado 2023

AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection

por Aksyuk, Anastasia A., Bansal, Himanshu, Wilkins, Deidre, Stanley, Ann Marie, Sproule, Stephanie, Maaske, Jill, Sanikommui, Satya, Hartman, William R., Sobieszczyk, Magdalena E., Falsey, Ann R., Kelly, Elizabeth J.
Publicado 2022

Next‐Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development

por Roth, Sharin E., Avigan, Mark I., Bourdet, David, Brott, David, Church, Rachel, Dash, Ajit, Keller, Douglas, Sherratt, Philip, Watkins, Paul B., Westcott‐Baker, Lucas, Lentini, Silvia, Merz, Michael, Ramaiah, Lila, Ramaiah, Shashi K., Stanley, Ann Marie, Marcinak, John
Publicado 2019

Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials

por Hey-Hadavi, Juliana, Seekins, Daniel, Palmer, Melissa, Coffey, Denise, Caminis, John, Abdullaev, Sandzhar, Patwardhan, Meenal, Tyler, Haifa, Raheja, Ritu, Stanley, Ann Marie, Pineda-Salgado, Liliam, Bourdet, David L., Andrade, Raul J., Hayashi, Paul H., Dimick-Santos, Lara, Rockey, Don C., Estilo, Alvin
Publicado 2021

Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials

por Ahani, Bahar, Tuffy, Kevin M., Aksyuk, Anastasia A., Wilkins, Deidre, Abram, Michael E., Dagan, Ron, Domachowske, Joseph B., Guest, Johnathan D., Ji, Hong, Kushnir, Anna, Leach, Amanda, Madhi, Shabir A., Mankad, Vaishali S., Simões, Eric A. F., Sparklin, Benjamin, Speer, Scott D., Stanley, Ann Marie, Tabor, David E., Hamrén, Ulrika Wählby, Kelly, Elizabeth J., Villafana, Tonya
Publicado 2023

Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated

por Maaske, Jill, Sproule, Stephanie, Falsey, Ann R., Sobieszczyk, Magdalena E., Luetkemeyer, Anne F., Paulsen, Grant C., Riddler, Sharon A., Robb, Merlin L., Rolle, Charlotte-Paige, Sha, Beverly E., Tong, Tina, Ahani, Bahar, Aksyuk, Anastasia A., Bansal, Himanshu, Egan, Timothy, Jepson, Brett, Padilla, Marcelino, Patel, Nirmeshkumar, Shoemaker, Kathryn, Stanley, Ann Marie, Swanson, Phillip A., Wilkins, Deidre, Villafana, Tonya, Green, Justin A., Kelly, Elizabeth J.
Publicado 2023

Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine

por Benkeser, David, Fong, Youyi, Janes, Holly E., Kelly, Elizabeth J., Hirsch, Ian, Sproule, Stephanie, Stanley, Ann Marie, Maaske, Jill, Villafana, Tonya, Houchens, Christopher R., Martins, Karen, Jayashankar, Lakshmi, Castellino, Flora, Ayala, Victor, Petropoulos, Christos J., Leith, Andrew, Haugaard, Deanne, Webb, Bill, Lu, Yiwen, Yu, Chenchen, Borate, Bhavesh, van der Laan, Lars W. P., Hejazi, Nima S., Carpp, Lindsay N., Randhawa, April K., Andrasik, Michele P., Kublin, James G., Isaacs, Margaret Brewinski, Makhene, Mamodikoe, Tong, Tina, Robb, Merlin L., Corey, Lawrence, Neuzil, Kathleen M., Follmann, Dean, Hoffman, Corey, Falsey, Ann R., Sobieszczyk, Magdalena, Koup, Richard A., Donis, Ruben O., Gilbert, Peter B.
Publicado 2023